These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

269 related articles for article (PubMed ID: 22205945)

  • 1. Mesenchymal stromal cells primed with paclitaxel provide a new approach for cancer therapy.
    Pessina A; Bonomi A; Coccè V; Invernici G; Navone S; Cavicchini L; Sisto F; Ferrari M; Viganò L; Locatelli A; Ciusani E; Cappelletti G; Cartelli D; Arnaldo C; Parati E; Marfia G; Pallini R; Falchetti ML; Alessandri G
    PLoS One; 2011; 6(12):e28321. PubMed ID: 22205945
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mesenchymal stromal cells primed with Paclitaxel attract and kill leukaemia cells, inhibit angiogenesis and improve survival of leukaemia-bearing mice.
    Pessina A; Coccè V; Pascucci L; Bonomi A; Cavicchini L; Sisto F; Ferrari M; Ciusani E; Crovace A; Falchetti ML; Zicari S; Caruso A; Navone S; Marfia G; Benetti A; Ceccarelli P; Parati E; Alessandri G
    Br J Haematol; 2013 Mar; 160(6):766-78. PubMed ID: 23293837
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Paclitaxel is incorporated by mesenchymal stromal cells and released in exosomes that inhibit in vitro tumor growth: a new approach for drug delivery.
    Pascucci L; Coccè V; Bonomi A; Ami D; Ceccarelli P; Ciusani E; Viganò L; Locatelli A; Sisto F; Doglia SM; Parati E; Bernardo ME; Muraca M; Alessandri G; Bondiolotti G; Pessina A
    J Control Release; 2014 Oct; 192():262-70. PubMed ID: 25084218
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Human skin-derived fibroblasts acquire in vitro anti-tumor potential after priming with Paclitaxel.
    Pessina A; Coccè V; Bonomi A; Cavicchini L; Sisto F; Ferrari M; Ciusani E; Navone S; Marfia G; Parati E; Alessandri G
    Anticancer Agents Med Chem; 2013 Mar; 13(3):523-30. PubMed ID: 22931415
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Human mesenchymal stromal cells inhibit tumor growth in orthotopic glioblastoma xenografts.
    Pacioni S; D'Alessandris QG; Giannetti S; Morgante L; Coccè V; Bonomi A; Buccarelli M; Pascucci L; Alessandri G; Pessina A; Ricci-Vitiani L; Falchetti ML; Pallini R
    Stem Cell Res Ther; 2017 Mar; 8(1):53. PubMed ID: 28279193
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mesenchymal stromal cells uptake and release paclitaxel without reducing its anticancer activity.
    Mariotti M; Colognato R; Rimoldi M; Rizzetto M; Sisto F; Cocce V; Bonomi A; Parati E; Alessandri G; Bagnati R; Pessina A
    Anticancer Agents Med Chem; 2015; 15(3):400-5. PubMed ID: 24942547
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Paclitaxel-releasing mesenchymal stromal cells inhibit in vitro proliferation of human mesothelioma cells.
    Petrella F; Coccè V; Masia C; Milani M; Salè EO; Alessandri G; Parati E; Sisto F; Pentimalli F; Brini AT; Pessina A; Spaggiari L
    Biomed Pharmacother; 2017 Mar; 87():755-758. PubMed ID: 28153512
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Adipose tissue-derived stromal cells primed in vitro with paclitaxel acquire anti-tumor activity.
    Bonomi A; Coccè V; Cavicchini L; Sisto F; Dossena M; Balzarini P; Portolani N; Ciusani E; Parati E; Alessandri G; Pessina A
    Int J Immunopathol Pharmacol; 2013; 26(1 Suppl):33-41. PubMed ID: 24046947
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mesenchymal stem cells loaded with paclitaxel-poly(lactic-
    Wang X; Gao J; Ouyang X; Wang J; Sun X; Lv Y
    Int J Nanomedicine; 2018; 13():5231-5248. PubMed ID: 30237710
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Human CD14+ cells loaded with Paclitaxel inhibit in vitro cell proliferation of glioblastoma.
    Bonomi A; Lisini D; Navone SE; Frigerio S; Dossena M; Ciusani E; Rampini P; Marfia G; Coccè V; Cavicchini L; Sisto F; Parati E; Mantegazza R; Rimoldi M; Rizzetto M; Alessandri G; Pessina A
    Cytotherapy; 2015 Mar; 17(3):310-9. PubMed ID: 25457277
    [TBL] [Abstract][Full Text] [Related]  

  • 11. HeLa Cell-Derived Paclitaxel-Loaded Microparticles Efficiently Inhibit the Growth of Cervical Carcinoma.
    Peng J; Zhao J; Zhao Y; Wu P; Gou L; Fu S; Chen P; Lu Y; Yang L
    Int J Nanomedicine; 2020; 15():6409-6420. PubMed ID: 32922008
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Adipose-derived stem cell-mediated paclitaxel delivery inhibits breast cancer growth.
    Scioli MG; Artuso S; D'Angelo C; Porru M; D'Amico F; Bielli A; Gentile P; Cervelli V; Leonetti C; Orlandi A
    PLoS One; 2018; 13(9):e0203426. PubMed ID: 30192811
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Antitumor effect of iRGD-modified liposomes containing conjugated linoleic acid-paclitaxel (CLA-PTX) on B16-F10 melanoma.
    Du R; Zhong T; Zhang WQ; Song P; Song WD; Zhao Y; Wang C; Tang YQ; Zhang X; Zhang Q
    Int J Nanomedicine; 2014; 9():3091-105. PubMed ID: 25028548
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Poly(ethylene glycol)-paclitaxel-alendronate self-assembled micelles for the targeted treatment of breast cancer bone metastases.
    Miller K; Clementi C; Polyak D; Eldar-Boock A; Benayoun L; Barshack I; Shaked Y; Pasut G; Satchi-Fainaro R
    Biomaterials; 2013 May; 34(15):3795-806. PubMed ID: 23434349
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Physcion-8-O-β-d-glucoside interferes with the nuclear factor-κB pathway and downregulates P-glycoprotein expression to reduce paclitaxel resistance in ovarian cancer cells.
    Li X; He Y; Wei L; Zhang J; Li X; Cui W; Zhang S
    J Pharm Pharmacol; 2021 Mar; 73(4):545-552. PubMed ID: 33793827
    [TBL] [Abstract][Full Text] [Related]  

  • 16. IFN-γ-primed human bone marrow mesenchymal stem cells induce tumor cell apoptosis in vitro via tumor necrosis factor-related apoptosis-inducing ligand.
    Du J; Zhou L; Chen X; Yan S; Ke M; Lu X; Wang Z; Yu W; Xiang AP
    Int J Biochem Cell Biol; 2012 Aug; 44(8):1305-14. PubMed ID: 22554587
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cancer-Associated Fibroblasts Share Characteristics and Protumorigenic Activity with Mesenchymal Stromal Cells.
    Borriello L; Nakata R; Sheard MA; Fernandez GE; Sposto R; Malvar J; Blavier L; Shimada H; Asgharzadeh S; Seeger RC; DeClerck YA
    Cancer Res; 2017 Sep; 77(18):5142-5157. PubMed ID: 28687621
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Delta-like ligand 4-targeted nanomedicine for antiangiogenic cancer therapy.
    Liu YR; Guan YY; Luan X; Lu Q; Wang C; Liu HJ; Gao YG; Yang SC; Dong X; Chen HZ; Fang C
    Biomaterials; 2015 Feb; 42():161-71. PubMed ID: 25542804
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The efficiency of tumor-specific pH-responsive peptide-modified polymeric micelles containing paclitaxel.
    Zhao BX; Zhao Y; Huang Y; Luo LM; Song P; Wang X; Chen S; Yu KF; Zhang X; Zhang Q
    Biomaterials; 2012 Mar; 33(8):2508-20. PubMed ID: 22197569
    [TBL] [Abstract][Full Text] [Related]  

  • 20. JD enhances the anti-tumour effects of low-dose paclitaxel on gastric cancer MKN45 cells both in vitro and in vivo.
    Wang C; Wang R; Zhou K; Wang S; Wang J; Shi H; Dou Y; Yang D; Chang L; Shi X; Liu Y; Xu X; Zhang X; Ke Y; Liu H
    Cancer Chemother Pharmacol; 2016 Nov; 78(5):971-982. PubMed ID: 27620208
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.